156 related articles for article (PubMed ID: 37820281)
21. Comparative effectiveness of therapies for Graves' hyperthyroidism: a systematic review and network meta-analysis.
Sundaresh V; Brito JP; Wang Z; Prokop LJ; Stan MN; Murad MH; Bahn RS
J Clin Endocrinol Metab; 2013 Sep; 98(9):3671-7. PubMed ID: 23824415
[TBL] [Abstract][Full Text] [Related]
22. Comparative Effectiveness of Treatment Choices for Graves' Hyperthyroidism: A Historical Cohort Study.
Sundaresh V; Brito JP; Thapa P; Bahn RS; Stan MN
Thyroid; 2017 Apr; 27(4):497-505. PubMed ID: 28049375
[TBL] [Abstract][Full Text] [Related]
23. Long-Term Antithyroid Drug Treatment of Graves' Disease in Children and Adolescents: A 20-Year Single-Center Experience.
Song A; Kim SJ; Kim MS; Kim J; Kim I; Bae GY; Seo E; Cho YS; Choi JY; Cho SY; Jin DK
Front Endocrinol (Lausanne); 2021; 12():687834. PubMed ID: 34194397
[TBL] [Abstract][Full Text] [Related]
24. Graves' disease in children.
Léger J; Oliver I; Rodrigue D; Lambert AS; Coutant R
Ann Endocrinol (Paris); 2018 Dec; 79(6):647-655. PubMed ID: 30180972
[TBL] [Abstract][Full Text] [Related]
25. Graves' disease in childhood.
Kraiem Z; Newfield RS
J Pediatr Endocrinol Metab; 2001 Mar; 14(3):229-43. PubMed ID: 11308041
[TBL] [Abstract][Full Text] [Related]
26. Treatment of Graves' hyperthyroidism: evidence-based and emerging modalities.
Hegedüs L
Endocrinol Metab Clin North Am; 2009 Jun; 38(2):355-71, ix. PubMed ID: 19328416
[TBL] [Abstract][Full Text] [Related]
27. Treatment of Graves' disease in children: The Portuguese experience.
Marques O; Antunes A; Oliveira MJ
Endocrinol Diabetes Nutr (Engl Ed); 2018 Mar; 65(3):143-149. PubMed ID: 29325833
[TBL] [Abstract][Full Text] [Related]
28. Epidemiology, management and outcomes of Graves' disease-real life data.
Hussain YS; Hookham JC; Allahabadia A; Balasubramanian SP
Endocrine; 2017 Jun; 56(3):568-578. PubMed ID: 28478488
[TBL] [Abstract][Full Text] [Related]
29. Long-term outcome of treatments for Graves disease in the children and adolescent population.
Jawwad M; Ahmed SA; Zaidi SMM; Fatmi SAA; Ashraf MH; Naeem S; Chola MS
Endocrine; 2023 Aug; 81(2):223-230. PubMed ID: 37115377
[TBL] [Abstract][Full Text] [Related]
30. The tale of radioiodine and Graves' orbitopathy.
Ponto KA; Zang S; Kahaly GJ
Thyroid; 2010 Jul; 20(7):785-93. PubMed ID: 20578895
[TBL] [Abstract][Full Text] [Related]
31. Approach to the Patient: Management and the Long-term Consequences of Graves' Disease in Children.
Rivkees SA
J Clin Endocrinol Metab; 2022 Nov; 107(12):3408-3417. PubMed ID: 36184734
[TBL] [Abstract][Full Text] [Related]
32. The treatment of Graves' disease in children.
Rivkees SA
J Pediatr Endocrinol Metab; 2006 Sep; 19(9):1095-111. PubMed ID: 17128557
[TBL] [Abstract][Full Text] [Related]
33. The adjunctive use of carbimazole during radioactive iodine treatment reduces the cure rate of Graves' disease.
Docrat F; Mokoena T; Karusseit VOL; Ankrah AO
S Afr Med J; 2021 Feb; 111(2):176-179. PubMed ID: 33944730
[TBL] [Abstract][Full Text] [Related]
34. Clinical Outcomes of Repeated Radioactive Iodine Therapy for Graves' Disease.
Kim MJ; Cho SW; Kim YA; Choi HS; Park YJ; Park DJ; Cho BY
Endocrinol Metab (Seoul); 2022 Jun; 37(3):524-532. PubMed ID: 35709827
[TBL] [Abstract][Full Text] [Related]
35. Should radioiodine be the first-line treatment for paediatric Graves' disease?
West JD; Cheetham TD; Dane C; Natarajan A
J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):797-804. PubMed ID: 25719296
[TBL] [Abstract][Full Text] [Related]
36. Cost-utility analysis comparing radioactive iodine, anti-thyroid drugs and total thyroidectomy for primary treatment of Graves' disease.
Donovan PJ; McLeod DS; Little R; Gordon L
Eur J Endocrinol; 2016 Dec; 175(6):595-603. PubMed ID: 27634939
[TBL] [Abstract][Full Text] [Related]
37. Cardiovascular Health by Graves' Disease Management Modality - Surgery Versus Radioactive Iodine Versus Antithyroid Medications: A Network Meta-Analysis.
Issa PP; Hussein M; Omar M; Munshi R; Attia AS; Buti Y; Aboueisha M; Shama M; Toraih E; Kandil E
J Surg Res; 2023 Mar; 283():266-273. PubMed ID: 36423475
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of long-term follow-up and methimazole therapy outcomes of pediatric Graves' disease: a single-center experience.
Bayramoğlu E; Elmaogulları S; Sagsak E; Aycan Z
J Pediatr Endocrinol Metab; 2019 Apr; 32(4):341-346. PubMed ID: 30862763
[TBL] [Abstract][Full Text] [Related]
39. Impaired immune regulation after radioiodine therapy for Graves' disease and the protective effect of Methimazole.
Côté-Bigras S; Tran V; Turcotte S; Rola-Pleszczynski M; Verreault J; Rottembourg D
Endocrine; 2016 Jun; 52(3):587-96. PubMed ID: 26701678
[TBL] [Abstract][Full Text] [Related]
40. Radioiodine treatment for pediatric Graves' disease.
Ma C; Kuang A; Xie J; Liu G
Cochrane Database Syst Rev; 2008 Jul; (3):CD006294. PubMed ID: 18646146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
